Percutaneous Coronary Intervention
PROTECT II Trial
A Prospective, Multi-center, Randomized Controlled Trial of the Impella® Recover LP 2.5 System Versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non-Emergent High Risk PCI
Principal Investigator
David E. Leeman, MD
Co-Investigators
Donald E. Cutlip, MD
Duane S. Pinto, MD
Samuel J. Shubrooks, Jr., MD
Coordinator
Paula Rooney, RN
Phone: 617-632-7484
Email: prooney@bidmc.harvard.edu
Focus: Patients undergoing non-emergency, high-risk percutaneous coronary intervention (PCI)
The PROTECT II trial is assessing the safety and effectiveness of the FED-approved Impella® Recover LP 2.5 System compared to intra-aortic balloon pump (IABP) use in subjects undergoing non-emergent high-risk percutaneous coronary intervention (PCI).
